Emend (aprepitant) blocks the actions of chemicals within the body that trigger nausea and reflex.

Emend is employed in adults and youngsters to stop nausea and reflex caused by cancer therapy. Aprepitant is additionally used (only in adults) to stop nausea and reflex that will be caused by surgery.

Emend is given before time and can not treat nausea or reflex that you just have already got.

Emend capsules ar to be used in adults and youngsters UN agency ar a minimum of twelve years recent. The oral suspension (liquid) are often given to adults and youngsters as young as half-dozen months recent.

Submit your review
1
2
3
4
5
Submit
     
Cancel

Create your own review

Average rating:  
 0 reviews
  • Emend, Emend 2-Day, Emend 3-Day
  • Get emergency medical help if you have signs of an allergic reaction to Emend: hives, skin sores, skin peeling; difficult breathing; swelling of your face, lips, tongue, or throat.

    Call your doctor at once if you have:

    low blood cell counts - fever, chills, flu-like symptoms, swollen gums, mouth sores, skin sores, rapid heart rate, pale skin, easy bruising, unusual bleeding, feeling light-headed;
    a light-headed feeling, like you might pass out; or
    dehydration symptoms - feeling very thirsty or hot, being unable to urinate, heavy sweating, or hot and dry skin.
    Common Emend side effects may include:

    stomach pain, indigestion, loss of appetite;
    diarrhea, constipation;
    hiccups;
    abnormal liver function tests;
    headache, dizziness;
    cough; or
    feeling weak or tired.
  • Usual Adult Dose for Nausea/Vomiting - Chemotherapy Induced: HIGHLY EMETOGENIC CANCER CHEMOTHERAPY: Day 1: 125 mg orally 1 hour prior to chemotherapy Day 2 and 3: 80 mg orally in the morning Duration of therapy: Three days Comments: -Emend is administered in conjunction with a corticosteroid and a 5-HT3 antagonist. -The recommended dosage of dexamethasone is 12 mg orally on day 1 administered 30 minutes prior to chemotherapy and 8 mg orally in the mornings on days 2 through 4. -The 5-HT3 antagonist is administered on day 1 only. Consult the package insert for the 5-HT3 antagonist dosing prior to initiation of treatment. -Aprepitant may be taken with or without food. Fosaprepitant dimeglumine for Injection (115 mg) may be substituted for oral aprepitant (125 mg), 30 minutes prior to chemotherapy, on Day 1 only of the CINV regimen as an intravenous infusion administered over 15 minutes. MODERATELY EMETOGENIC CANCER CHEMOTHERAPY: Day 1: 125 mg orally 1 hour prior to chemotherapy Day 2 and 3: 80 mg orally in the morning Duration of therapy: Three days Comments: -Aprepitant is administered in conjunction with a corticosteroid and a 5-HT3 antagonist. -The recommended dosage of dexamethasone is 12 mg orally on day 1 administered 30 minutes prior to chemotherapy. -The 5-HT3 antagonist is administered on day 1 only. Consult the package insert for the 5-HT3 antagonist dosing prior to initiation of treatment. -Aprepitant may be taken with or without food. Usual Adult Dose for Nausea/Vomiting - Postoperative: Recommended dose: a single, oral 40 mg dose administered within 3 hours prior to the induction of anesthesia